Liver Cirrhosis, Biliary

• 

  Subject Areas on Research

  • A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis. 
  • Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis. 
  • Anticomplement receptor activity in the serum of patients with primary biliary cirrhosis. 
  • Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. 
  • Bile ductules and stromal cells express hedgehog ligands and/or hedgehog target genes in primary biliary cirrhosis. 
  • Cis-acting polymorphisms affect complex traits through modifications of microRNA regulation pathways. 
  • Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis. 
  • Co-occurrence of idiopathic granulomatous hepatitis and primary biliary cirrhosis. 
  • Coexistence of autoimmune pancreatitis and primary biliary cirrhosis in a Caucasian patient - a rare cause of cholestasis. 
  • Computer-guided randomized concentration-controlled trials of tacrolimus in autoimmunity: multiple sclerosis and primary biliary cirrhosis. 
  • Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. 
  • Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation. 
  • Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis. 
  • Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection. 
  • Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis. 
  • Late presentation of a biliary tract complication after right hepatic donation resulting in secondary biliary cirrhosis. 
  • Liver transplantation and autoimmunity. 
  • Liver transplantation in autoimmune liver disease--selection of patients. 
  • NIH conference. Primary biliary cirrhosis and the complement system. 
  • Non-parametric estimation of a time-dependent predictive accuracy curve. 
  • Noninvasive markers in the assessment and management of autoimmune liver diseases. 
  • Palmar lipid deposits and profound hypercholesterolemia that resolved after orthotopic liver transplantation for primary biliary cirrhosis. 
  • Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology. 
  • Primary biliary cirrhosis and type II autoimmune polyglandular syndrome. 
  • Primary biliary cirrhosis: new therapeutic directions. 
  • Quality of life and everyday activities in patients with primary biliary cirrhosis. 
  • Quantitative analysis of macrophages and perisinusoidal cells in primary biliary cirrhosis. 
  • Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis. 
  • Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production. 
  • Surgical portosystemic shunts for treatment of portal hypertensive bleeding: outcome and effect on liver function. 
  • Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis. 
  • Takotsubo cardiomyopathy in a liver transplant recipient: a diagnosis of exclusion? 
  • The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis. 
  • The pathology of primary biliary cirrhosis. 
  • Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis. 
• 

  Keywords of People

  • Choi, Steven Sok, Associate Professor of Medicine, Medicine, Gastroenterology